Clinical Trial Update: Efficacy and Safety of Valsartan/Amlodipine Compared to Amlodipine in Patients With Essential Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial comparing the fixed-dose combination valsartan/amlodipine to amlodipine alone in patients with essential hypertension; the study evaluated efficac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• Amlodipine (amlodipine)
• Valsartan/amlodipine (Valsartan/amlodipine)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Essential Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2011-02-14